DaVita
DVA
#2385
Rank
NZ$12.98 B
Marketcap
NZ$181.55
Share price
1.96%
Change (1 day)
-42.61%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.16

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$16.50. In 2024 the company made an earnings per share (EPS) of NZ$18.31 an increase over its 2023 EPS that were of NZ$12.64.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.16-6.3%
2024NZ$18.3144.94%
2023NZ$12.6427.26%
2022NZ$9.93-35.56%
2021NZ$15.4144.1%
2020NZ$10.6919.7%
2019NZ$8.93540.48%
2018NZ$1.39-76.07%
2017NZ$5.83-19.31%
2016NZ$7.22242.52%
2015NZ$2.11-62.87%
2014NZ$5.6813.43%
2013NZ$5.018.45%
2012NZ$4.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$35.45 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.02 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$24.41 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.15-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA